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Abstract: 
Introduction: Hypertension is one of the important risk factors for cardiovascular disease, which is the major cause 
of morbidity and mortality worldwide. In particular, changes in systemic calcium metabolism are thought to play an 
important role in the regulation of blood pressure. Objectives of the study: The basic aim of the study is to find the 
role of parathyroid hormone in hypertension and blood pressure. Material and methods: This cross sectional study 
was conducted at Services Institute of Medical Sciences, Lahore during February 2018 to November 2018. This study 
was conducted on 100 patients which was suffering from hypertension and visit the OPD of hospital regularly. Venous 
blood samples were drawn after overnight fasting for the measurement of serum glucose, creatinine and total 
cholesterol. Serum was also stored at −30°C for measurement of PTH. Serum calcium, phosphorous, and albumin 
were measured. BP was obtained using an automatic BP monitor. Three measures were taken at rest in a sitting 
position, with intervals of 5 min between the measurements. The average from the last two measurements was taken 
for analysis. Results: Calcium and PTH levels significantly decreased in all hypertensive patients with a cure rate of 
99.1%. The mean systolic and diastolic BP decreased in the total population of hypertensive patients and hypertensive 
patients on antihypertensive therapy. Patients with PHPT experienced a significant decrease in both systolic BP (P < 
.001) and diastolic BP. High BP was present in 34% of the whole sample, and another 16% were taking medication 
for hypertension. Conclusion: It is concluded that serum vitamin D and PTH levels are not independently associated 
with blood pressure or risk of hypertension. Hypertension associated with common endocrine conditions which are 
not classically considered to be etiologies involved in the work up of a patient with suspected secondary hypertension.  
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INTRODUCTION: 
Hypertension is one of the important risk factors for 
cardiovascular disease, which is the major cause of 
morbidity and mortality worldwide. In particular, 
changes in systemic calcium metabolism are thought 
to play an important role in the regulation of blood 
pressure [1]. One hypothesis for this link implicates 
parathyroid hormone (PTH). Serum calcium level is 
tightly regulated by PTH in a classic negative-
feedback system. A small decrease in serum calcium 
stimulates an abrupt increase in PTH secretion, which 
leads to calcium mobilization from bone, increased 
renal tubular calcium reabsorption and increased renal 
hydroxylation of 25-hydroxyvitamin D to the 
biologically more active 1,25-dihydroxyvitamin D [2]. 
 
Thyroid gland along with the parathyroid glands and 
heart share a close relationship arising in embryology. 
In ontogeny, the thyroid and heart migrate together. 
There is a strong physiological relationship between 
the two organs, which is affirmed by predictable 
changes in cardiovascular functions across the entire 
range of thyroid disease states [3]. Many symptoms 
and signs recognized in patients with overt 
hyperthyroidism and hypothyroidism are due to 
increased or reduced action of thyroid hormone on the 
heart and the vascular system, respectively [4]. 
 
Increases in parathyroid hormone (PTH) have been 
associated with changes in the vascular tone and renin 
angiotensin system. Hyper functioning parathyroid 
glandular disorders have been for long associated with 
an increased risk of hypertension, though a causal 
relationship is still not established [5]. Most of the 
molecular and cellular mechanisms responsible for the 
cardiovascular effects of the thyroid hormone have 
been clarified. Thyroid hormone exerts both genomic 
and non-genomic effects on cardiac myocytes. Studies 
have confirmed T3 as the active form of thyroid 
hormone that accounts for the vast majority of thyroid 
effects including stimulation of tissue thermogenesis, 
alterations in the expression of various cellular 
proteins and action on the heart and vascular smooth 
muscle cells. The process of the genomic effect of 
thyroid hormone begins with the entry of T3 into the 
cardio myocyte through specific transport proteins 
located within the cell membrane [6]. 
 
Objectives of the study 
The basic aim of the study is to find the role of 
parathyroid hormone in hypertension and blood 
pressure. 
 
MATERIAL AND METHODS: 
This cross sectional study was conducted at Services 
Institute of Medical Sciences, Lahore during February 
2018 to November 2018. This study was conducted on 
100 patients which was suffering from hypertension 
and visit the OPD of hospital regularly. Venous blood 
samples were drawn after overnight fasting for the 
measurement of serum glucose, creatinine and total 
cholesterol. Serum was also stored at −30°C for 
measurement of PTH. Serum calcium, phosphorous, 
and albumin were measured. BP was obtained using 
an automatic BP monitor. Three measures were taken 
at rest in a sitting position, with intervals of 5 min 
between the measurements. The average from the last 
two measurements was taken for analysis.  
 
Statistical Analyses 
Comparisons between the two groups were done using 
the t test or the chi-square, where appropriate. Data 
analysis was carried out using the SPSS software 
(Statistical Package for the Social Sciences, version 
15.0, SPSS Inc, Chicago, Ill, USA). 
 
RESULTS: 
Calcium and PTH levels significantly decreased in all 
hypertensive patients with a cure rate of 99.1%. The 
mean systolic and diastolic BP decreased in the total 
population of hypertensive patients and hypertensive 
patients on antihypertensive therapy. Patients with 
PHPT experienced a significant decrease in both 
systolic BP (P < .001) and diastolic BP. High BP was 
present in 34% of the whole sample, and another 16% 
were taking medication for hypertension. Overweight 
and obesity was present in 75% of the individuals. 
Only 23% of whole sample reported practice regular 
physical exercise and the use of sunscreen was present 
in 22% of individuals. 
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Table 01: Analysis of relationship of hyperthyroidism and hypertension  
25(OH)D (ng/ml) 
 
 
<16.8 16.8–22.5 22.6–28.3 >28.3 
 
 
(n = 295) (n = 310) (n = 301) (n = 300) P 
25(OH)D, ng/ml 12.8±2.8 19.7±1.6 25.3±1.6 34.0±4.8 – 
PTH, pmol/l 3.12 2.89 2.54 2.52 0.0001  
(2.04–4.42) (1.91–3.99) (1.80–3.61) (1.65–3.66) 
 
Study outcome 
     
Systolic BP, mmHg 124.4±18.6 124.7±19.4 124.6±17.9 123.4±17.5 0.84 
Diastolic BP, mmHg 77.7±11.6 78.4±11.1 78.8±11.5 77.7±11.0 0.60 
Pulse pressure, mmHg 46.6±11.5 46.3±12.3 45.8±10.4 45.7±10.5 0.69 
Possible confounders 
     
Male, % 50.2 58.1 65.5 67.7 <0.0001 
Age, years 49.5±13.4 47.0±11.9 45.9±11.9 45.6±12.3 0.0004 
BMI, kg/m2 23.0±3.2 23.4±3.4 23.3±3.2 23.1±3.2 0.42 
Total cholesterol, mmol/l 5.6±1.2 5.4±1.1 5.4±1.0 5.3±1.0 0.02 
Serum glucose, mmol/l 5.4±2.0 5.4±1.8 5.2±1.7 5.2±1.5 0.23 
GFR, ml/min.1.73 m2 97.6±19.3 95.3±18.4 97.2±21.0 94.2±18.2 0.10 
Hypertension, % 23.4 22.3 22.6 22.3 0.99 
 
DISCUSSION: 
The main findings of our cross-sectional study are that 
serum 25(OH)D and PTH levels are not independently 
associated with blood pressure level or risk of 
hypertension. Subclinical hyperthyroidism is 
characterized by subnormal thyrotropin (TSH) serum 
levels in the presence of circulating thyroid hormones 
in the normal range for the general population. It may 
be due to an intrinsic pathology of the thyroid gland 
(endogenous subclinical hyperthyroidism) or a 
consequent suppressive or replacement l-thyroxine 
therapy (exogenous subclinical hyperthyroidism). 
Exogenous subclinical hyperthyroidism is the 
condition more frequently seen in clinical practice [7]. 
 
A number of studies have investigated the effects of 
subclinical hyperthyroidism on the heart, showing that 
this condition may be associated with various 
abnormalities of cardiac structure and function. The 
cardiovascular disorders associated with subclinical 
hyperthyroidism may be a direct effect of thyroid 
hormone disturbance or may reflect an increased 
arterial pressure level in these patients [8]. There are 
no consistent studies proving that arterial BP rises in 
such patients. Recent meta-analyses of five large 
studies evaluating the incidence of hypertension in 
these patients did not reveal increased BP levels in 
individuals with suppressed serum TSH levels and free 
thyroid hormones within the reference range [9]. The 
finding that serum PTH level was not associated with 
blood pressure level or risk of hypertension is in 
contrast to previous studies. Several studies have 
consistently demonstrated that higher levels of 
circulating PTH were associated with higher blood 
pressure or prevalence of hypertension [10]. 
 
CONCLUSION: 
It is concluded that serum vitamin D and PTH levels 
are not independently associated with blood pressure 
or risk of hypertension. Hypertension associated with 
common endocrine conditions which are not 
classically considered to be etiologies involved in the 
work up of a patient with suspected secondary 
hypertension.  
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